News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Classifieds |
Employment |
Obituary |
Business
-
Briefly
Lupin ties up with Cornerstone
MUMBAI,
JAN. 27.
Lupin Pharmaceuticals Inc (LPI), the wholly-owned subsidiary of Lupin, has entered into an alliance with Cornerstone BioPharma Inc as a promotion partner in the U.S. for its Suprax (cefixime) anti-infective.
"Commencing immediately, Cornerstone's sales force will co-promote Suprax with a focus on primary care physicians, who were not covered by us. This partnership represents a significant expansion in the scope of physician coverage for Suprax in the $1.2 billion oral suspension anti-infective market," LPI MD and President Vinita Gupta said in a release here today.
PTI
Printer friendly
page
Send this article to Friends by
E-Mail
Business
News:
Front Page |
National |
Tamil Nadu |
Andhra Pradesh |
Karnataka |
Kerala |
New Delhi |
Other States |
International |
Opinion |
Business |
Sport |
Miscellaneous |
Engagements |
Advts:
Classifieds |
Employment |
Obituary |
Updates:
Breaking News |
|
